| Pathologic antibodies to platelet factor 4 after ChAdOx1 nCoV-19 vaccination M Scully, D Singh, R Lown, A Poles, T Solomon, M Levi, D Goldblatt, ... New England Journal of Medicine 384 (23), 2202-2211, 2021 | 1062 | 2021 |
| AAV5–factor VIII gene transfer in severe hemophilia A S Rangarajan, L Walsh, W Lester, D Perry, B Madan, M Laffan, H Yu, ... New England Journal of Medicine 377 (26), 2519-2530, 2017 | 717 | 2017 |
| Clinical features of vaccine-induced immune thrombocytopenia and thrombosis S Pavord, M Scully, BJ Hunt, W Lester, C Bagot, B Craven, A Rampotas, ... New England Journal of Medicine 385 (18), 1680-1689, 2021 | 558 | 2021 |
| Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis … A Goodeve, J Eikenboom, G Castaman, F Rodeghiero, AB Federici, ... Blood 109 (1), 112-121, 2007 | 472 | 2007 |
| Multiyear follow-up of AAV5-hFVIII-SQ gene therapy for hemophilia A KJ Pasi, S Rangarajan, N Mitchell, W Lester, E Symington, B Madan, ... New England Journal of Medicine 382 (1), 29-40, 2020 | 418 | 2020 |
| The diagnosis and management of von Willebrand disease: a United Kingdom Haemophilia Centre Doctors Organization guideline approved by the British Committee for Standards in … MA Laffan, W Lester, JS O'Donnell, A Will, RC Tait, A Goodeve, CM Millar, ... British journal of haematology 167 (4), 453, 2014 | 418 | 2014 |
| Thrombotic thrombocytopenic purpura and pregnancy: presentation, management, and subsequent pregnancy outcomes M Scully, M Thomas, M Underwood, H Watson, K Langley, RS Camilleri, ... Blood, The Journal of the American Society of Hematology 124 (2), 211-219, 2014 | 283 | 2014 |
| Guidelines on the use of liver biopsy in clinical practice from the British Society of Gastroenterology, the Royal College of Radiologists and the Royal College of Pathology J Neuberger, J Patel, H Caldwell, S Davies, V Hebditch, C Hollywood, ... Gut 69 (8), 1382-1403, 2020 | 278 | 2020 |
| An investigation of the von Willebrand factor genotype in UK patients diagnosed to have type 1 von Willebrand disease A Cumming, P Grundy, S Keeney, W Lester, S Enayat, A Guilliatt, ... Thrombosis and haemostasis 96 (11), 630-641, 2006 | 187 | 2006 |
| Endoscopy in patients on antiplatelet or anticoagulant therapy: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guideline update AM Veitch, F Radaelli, R Alikhan, JM Dumonceau, D Eaton, J Jerrome, ... Endoscopy 53 (09), 947-969, 2021 | 160 | 2021 |
| Characterization and treatment of congenital thrombotic thrombocytopenic purpura F Alwan, C Vendramin, R Liesner, A Clark, W Lester, T Dutt, W Thomas, ... Blood, The Journal of the American Society of Hematology 133 (15), 1644-1651, 2019 | 148 | 2019 |
| Presenting ADAMTS13 antibody and antigen levels predict prognosis in immune-mediated thrombotic thrombocytopenic purpura F Alwan, C Vendramin, K Vanhoorelbeke, K Langley, V McDonald, ... Blood, The Journal of the American Society of Hematology 130 (4), 466-471, 2017 | 126 | 2017 |
| Rituximab prophylaxis to prevent thrombotic thrombocytopenic purpura relapse: outcome and evaluation of dosing regimens JP Westwood, M Thomas, F Alwan, V McDonald, S Benjamin, WA Lester, ... Blood advances 1 (15), 1159-1166, 2017 | 103 | 2017 |
| Identification and characterization of a novel P2Y12 variant in a patient diagnosed with type 1 von Willebrand disease in the European MCMDM-1VWD study ME Daly, BB Dawood, WA Lester, IR Peake, F Rodeghiero, AC Goodeve, ... Blood, The Journal of the American Society of Hematology 113 (17), 4110-4113, 2009 | 85 | 2009 |
| Persistence of haemostatic response following gene therapy with valoctocogene roxaparvovec in severe haemophilia A KJ Pasi, M Laffan, S Rangarajan, TM Robinson, N Mitchell, W Lester, ... Haemophilia 27 (6), 947-956, 2021 | 84 | 2021 |
| Vaccine‐induced immune thrombocytopenia and thrombosis (VITT) M Makris, S Pavord, W Lester, M Scully, B Hunt Research and practice in thrombosis and haemostasis 5 (5), 2021 | 81 | 2021 |
| Interindividual variability in transgene mRNA and protein production following adeno-associated virus gene therapy for hemophilia A S Fong, B Yates, CR Sihn, AN Mattis, N Mitchell, S Liu, CB Russell, B Kim, ... Nature medicine 28 (4), 789-797, 2022 | 69 | 2022 |
| Laboratory coagulation tests and emicizumab treatment A United Kingdom haemophilia centre doctors' organisation guideline PV Jenkins, A Bowyer, C Burgess, E Gray, S Kitchen, P Murphy, S Platton, ... Haemophilia 26 (1), 151-155, 2020 | 66 | 2020 |
| Addendum to British Society for Haematology Guidelines on Investigation and Management of Antiphospholipid syndrome, 2012 (Br. J. Haematol. 2012; 157: 47-58): use of direct … DRJ Arachchillage, K Gomez, R Alikhan, JAM Anderson, W Lester, ... Br J Haematol 189 (2), 212-215, 2020 | 62 | 2020 |
| Fatal venous thromboembolism associated with hospital admission: a cohort study to assess the impact of a national risk assessment target W Lester, N Freemantle, I Begaj, D Ray, J Wood, D Pagano Heart 99 (23), 1734-1739, 2013 | 62 | 2013 |
